{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:31:53Z","timestamp":1787949113336,"version":"build-2784847793"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T00:00:00Z","timestamp":1258156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00223-009-9309-8","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T20:57:49Z","timestamp":1258145869000},"page":"465-483","source":"Crossref","is-referenced-by-count":92,"title":["Biology and Clinical Significance of Tartrate-Resistant Acid Phosphatases: New Perspectives on an Old Enzyme"],"prefix":"10.1007","volume":"85","author":[{"given":"Anthony J.","family":"Janckila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung T.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,14]]},"reference":[{"key":"9309_CR1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0002-9343(74)90630-5","volume":"56","author":"LT Yam","year":"1974","unstructured":"Yam LT (1974) Clinical significance of the human acid phosphatases. Am J Med 56:604\u2013616","journal-title":"Am J Med"},{"key":"9309_CR2","first-page":"111","volume":"5","author":"BC Antanaitis","year":"1983","unstructured":"Antanaitis BC, Aisen P (1983) Uteroferrin and the purple acid phosphatases. Adv Inorg Biochem 5:111\u2013136","journal-title":"Adv Inorg Biochem"},{"key":"9309_CR3","first-page":"359","volume":"8","author":"HG Drexler","year":"1994","unstructured":"Drexler HG, Gignac SM (1994) Characterization and expression of tartrate-resistant acid phosphatase (TRAP) in hemopoietic cells. Leukemia 8:359\u2013368","journal-title":"Leukemia"},{"key":"9309_CR4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/10428190009113378","volume":"39","author":"EC Lamp","year":"2000","unstructured":"Lamp EC, Drexler HG (2000) Biology of tartrate-resistant acid phosphatase. Leuk Lymphoma 39:477\u2013484","journal-title":"Leuk Lymphoma"},{"key":"9309_CR5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S8756-3282(00)00368-9","volume":"27","author":"GW Oddie","year":"2000","unstructured":"Oddie GW, Schenk G, Angel NZ, Walsh N, Guddat LW, de Jersey J, Cassady AI, Hamilton SE, Hume DA (2000) Structure, function, and regulation of tartrate-resistant acid phosphatase. Bone 27:575\u2013584","journal-title":"Bone"},{"key":"9309_CR6","first-page":"4639","volume":"25","author":"S Mose","year":"2005","unstructured":"Mose S, Menzel C, Kurth AA, Obert K, Ramm U, Eberlein K, Boettcher HD, Pichlmeier U (2005) Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as bone resorption marker in irradiated bone metastasis. Anticancer Res 25:4639\u20134646","journal-title":"Anticancer Res"},{"key":"9309_CR7","first-page":"499","volume":"52","author":"JM Halleen","year":"2006","unstructured":"Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Vaananen HK (2006) Tartrate-resistant acid phosphatase 5b (TRAP 5b) as a marker of bone resorption. Clin Lab 52:499\u2013509","journal-title":"Clin Lab"},{"key":"9309_CR8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI100974","volume":"17","author":"AB Gutman","year":"1938","unstructured":"Gutman AB, Gutman EB (1938) An \u201cacid\u201d phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest 17:473\u2013478","journal-title":"J Clin Invest"},{"key":"9309_CR9","first-page":"63","volume":"44","author":"AB Gutman","year":"1968","unstructured":"Gutman AB (1968) The development of the acid phosphatase test for prostatic carcinoma. Bull N Y Acad Med 44:63\u201376","journal-title":"Bull N Y Acad Med"},{"key":"9309_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/7.1.39","volume":"7","author":"MS Burstone","year":"1959","unstructured":"Burstone MS (1959) Chemical demonstration of acid phosphatase activity in osteoclasts. J Histochem Cytochem 7:39\u201341","journal-title":"J Histochem Cytochem"},{"key":"9309_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3181\/00379727-134-34768","volume":"134","author":"JE Wergedal","year":"1970","unstructured":"Wergedal JE (1970) Characterization of bone acid phosphatase activity. Proc Soc Exp Biol Med 134:224\u2013227","journal-title":"Proc Soc Exp Biol Med"},{"key":"9309_CR12","first-page":"1502","volume":"50","author":"JS Hanker","year":"1971","unstructured":"Hanker JS, Hammarstrom LE, Toverud SU (1971) Functional distribution of acid phosphatase in developing bones and teeth. J Dent Res 50:1502\u20131503","journal-title":"J Dent Res"},{"key":"9309_CR13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0005-2744(73)90387-2","volume":"293","author":"M Lieberherr","year":"1973","unstructured":"Lieberherr M, Vreven J, Vaes G (1973) The acid and alkaline phosphatases, inorganic pyrophosphatases and phosphoprotein phosphatase of bone. I. Characterization and assay. Biochim Biophys Acta 293:160\u2013169","journal-title":"Biochim Biophys Acta"},{"key":"9309_CR14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/18.7.473","volume":"18","author":"CY Li","year":"1970","unstructured":"Li CY, Yam LT, Lam KW (1970) Acid phosphatase isoenzyme in human leukocytes in normal and pathological conditions. J Histochem Cytochem 18:473\u2013481","journal-title":"J Histochem Cytochem"},{"key":"9309_CR15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/18.12.901","volume":"18","author":"CY Li","year":"1970","unstructured":"Li CY, Yam LT, Lam KW (1970) Studies of acid phosphatase isoenzymes in human leukocytes: demonstration of isoenzyme cell specificity. J Histochem Cytochem 18:901\u2013910","journal-title":"J Histochem Cytochem"},{"key":"9309_CR16","first-page":"1003","volume":"21","author":"A Taira","year":"2007","unstructured":"Taira A, Merrick G, Wallner K, Dattoli M (2007) Reviving the acid phosphatase test for prostate cancer. Oncology 21:1003\u20131010","journal-title":"Oncology"},{"key":"9309_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM197102182840707","volume":"284","author":"LT Yam","year":"1971","unstructured":"Yam LT, Li CY, Lam KW (1971) Tartrate-resistant acid phosphatase isoenzymes in the reticulum cells of leukemic reticuloendotheliosis. N Engl J Med 284:367\u2013369","journal-title":"N Engl J Med"},{"key":"9309_CR18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/clinchem\/26.3.420","volume":"26","author":"KW Lam","year":"1980","unstructured":"Lam KW, Lee P, Li CY, Yam LT (1980) Immunological and biochemical evidence for identity of tartrate-resistant isoenzymes of acid phosphatases from human serum and tissues. Clin Chem 26:420\u2013422","journal-title":"Clin Chem"},{"key":"9309_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02411252","volume":"34","author":"C Minkin","year":"1982","unstructured":"Minkin C (1982) Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34:285\u2013290","journal-title":"Calcif Tissue Int"},{"key":"9309_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0009-8981(83)90404-7","volume":"30","author":"JJ \u0160t\u0115p\u00e1n","year":"1983","unstructured":"\u0160t\u0115p\u00e1n JJ, Silinkov\u00e1-M\u00e1lkov\u00e1 E, Havr\u00e1nek T, Form\u00e1nkov\u00e1 J, Zichov\u00e1 M, Lachmanov\u00e1 J, Strakov\u00e1 M, Broulik P, Pacovsky V (1983) Relationship of plasma tartrate-resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clin Chim Acta 30:189\u2013200","journal-title":"Clin Chim Acta"},{"key":"9309_CR21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/clinchem\/33.4.458","volume":"33","author":"KH Lau","year":"1987","unstructured":"Lau KH, Onishi T, Werdegal JE, Singer FR, Baylink DJ (1987) Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 33:458\u2013462","journal-title":"Clin Chem"},{"key":"9309_CR22","first-page":"177","volume":"3","author":"J \u0160t\u0115p\u00e1n","year":"1987","unstructured":"\u0160t\u0115p\u00e1n J, Lachmanov\u00e1 J, Strakov\u00e1 M, Pacovsky V (1987) Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate-resistant acid phosphatase in patients on chronic maintenance hemodialysis. Bone Miner 3:177\u2013183","journal-title":"Bone Miner"},{"key":"9309_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF02556018","volume":"45","author":"JJ \u0160t\u0115p\u00e1n","year":"1989","unstructured":"\u0160t\u0115p\u00e1n JJ, Posp\u00edchal J, Schreiber V, Kanka J, Mensik J, Presl J, Pacovsky V (1989) The application of plasma tartrate-resistant acid phosphatase to assess changes in bone response to artificial menopause and its treatment with estrogen or norethisterone. Calcif Tissue Int 45:273\u2013280","journal-title":"Calcif Tissue Int"},{"key":"9309_CR24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02555896","volume":"49","author":"R Torres","year":"1991","unstructured":"Torres R, de la Piedra C, Rapado A (1991) Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget\u2019s disease of bone: correlation with other biochemical markers of bone remodeling. Calcif Tissue Int 49:14\u201316","journal-title":"Calcif Tissue Int"},{"key":"9309_CR25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/00365519109104560","volume":"51","author":"L Scarneccia","year":"1991","unstructured":"Scarneccia L, Minisola S, Pacitti MT, Carnevale V, Romagnoli E, Rosso R, Mazzuoli GF (1991) Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand J Clin Lab Invest 51:517\u2013524","journal-title":"Scand J Clin Lab Invest"},{"key":"9309_CR26","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/1097-0142(19800501)45:9<2400::AID-CNCR2820450927>3.0.CO;2-N","volume":"45","author":"M Tavassoli","year":"1980","unstructured":"Tavassoli M, Rizo M, Yam LT (1980) Elevation of serum acid phosphatase in cancers with bone metastasis. Cancer 45:2400\u20132403","journal-title":"Cancer"},{"key":"9309_CR27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/clinchem\/30.3.457","volume":"30","author":"KW Lam","year":"1984","unstructured":"Lam KW, Dannaher C, Letchford S, Eastlund T, Li CY, Yam LT (1984) Tartrate-resistant acid phosphatase in serum of cancer patients. Clin Chem 30:457\u2013459","journal-title":"Clin Chem"},{"key":"9309_CR28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/172460089000500202","volume":"5","author":"M Monti","year":"1990","unstructured":"Monti M, Scazzoso A, Calzaferri G, Santi I, D\u2019Aprile E, Cunietti E (1990) Tartrate-resistant acid phosphatase (TRAP) activity in serum: potential use in assessing bone resorption in patients with multiple myeloma. Int J Biol Markers 5:61\u201364","journal-title":"Int J Biol Markers"},{"key":"9309_CR29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0009-9120(05)80021-9","volume":"24","author":"B Desoize","year":"1991","unstructured":"Desoize B, Amico S, Larbre H, Coninx P, Jardillier JC (1991) Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma. Clin Biochem 24:443\u2013446","journal-title":"Clin Biochem"},{"key":"9309_CR30","first-page":"1106","volume":"24","author":"KW Lam","year":"1978","unstructured":"Lam KW, Eastlund T, Lin CY, Yam LT (1978) Biochemical properties of the tartrate-resistant acid phosphatase in serum of adults and children. Clin Chem 24:1106\u20131108","journal-title":"Clin Chem"},{"key":"9309_CR31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/clinchem\/25.5.719","volume":"25","author":"J Chen","year":"1979","unstructured":"Chen J, Yam LT, Janckila AJ, Li CY, Lam KW (1979) Significance of \u201chigh\u201d acid phosphatase activity in the serum of normal children. Clin Chem 25:719\u2013722","journal-title":"Clin Chem"},{"key":"9309_CR32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0009-8981(85)90090-7","volume":"151","author":"JJ \u0160t\u0115p\u00e1n","year":"1985","unstructured":"\u0160t\u0115p\u00e1n JJ, Tesa\u0159ov\u00e1 A, Havr\u00e1nek T, Jodl J, Form\u00e1nkov\u00e1 J, Pacovsky V (1985) Age and sex dependency of the biochemical indices of bone remodeling. Clin Chim Acta 151:273\u2013283","journal-title":"Clin Chim Acta"},{"key":"9309_CR33","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/20.12.1049","volume":"20","author":"CY Li","year":"1972","unstructured":"Li CY, Yam LT, Crosby WH (1972) Histochemical characterization of cellular and structural elements of the human spleen. J Histochem Cytochem 20:1049\u20131058","journal-title":"J Histochem Cytochem"},{"key":"9309_CR34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/hon.2900010404","volume":"1","author":"HJ Radzun","year":"1983","unstructured":"Radzun HJ, Kreipe H, Parwaresch MR (1983) Tartrate-resistant acid phosphatase as a differentiation marker for the human mononuclear phagocyte system. Hematol Oncol 1:321\u2013327","journal-title":"Hematol Oncol"},{"key":"9309_CR35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood.V67.3.729.729","volume":"67","author":"RG Snipes","year":"1986","unstructured":"Snipes RG, Lam KW, Dodd RC, Gray TK, Cohen MS (1986) Acid phosphatase activity in mononuclear phagocytes and the U937 cell line: monocyte-derived macrophages express tartrate-resistant acid phosphatase. Blood 67:729\u2013734","journal-title":"Blood"},{"key":"9309_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(92)90344-P","volume":"209","author":"DW Moss","year":"1992","unstructured":"Moss DW (1992) Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclasts and other macrophages. Clin Chim Acta 209:131\u2013138","journal-title":"Clin Chim Acta"},{"key":"9309_CR37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-9120(81)91201-7","volume":"14","author":"KW Lam","year":"1981","unstructured":"Lam KW, Li CY, Yam LT, Desnick RJ (1981) Comparison of the tartrate-resistant acid phosphatase in Gaucher\u2019s disease and leukemic reticuloendotheliosis. Clin Biochem 14:177\u2013181","journal-title":"Clin Biochem"},{"key":"9309_CR38","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/jbmr.5650111011","volume":"11","author":"J Halleen","year":"1996","unstructured":"Halleen J, Hentunen TA, Hellman J, V\u00e4\u00e4n\u00e4nen HK (1996) Tartrate-resistant acid phosphatase from human bone: purification and development of an immunoassay. J Bone Miner Res 11:1444\u20131452","journal-title":"J Bone Miner Res"},{"key":"9309_CR39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/clinchem\/47.1.74","volume":"47","author":"AJ Janckila","year":"2001","unstructured":"Janckila AJ, Takahashi K, Sun SZ, Yam LT (2001) Tartrate-resistant acid phosphatase isoform 5b as a serum marker for osteoclastic activity. Clin Chem 47:74\u201380","journal-title":"Clin Chem"},{"key":"9309_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-9861(86)90541-2","volume":"247","author":"TR Anderson","year":"1986","unstructured":"Anderson TR, Toverud SU (1986) Purification and characterization of purple acid phosphatase from developing rat bone. Arch Biochem Biophys 247:131\u2013139","journal-title":"Arch Biochem Biophys"},{"key":"9309_CR41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/bj2610601","volume":"261","author":"AR Hayman","year":"1989","unstructured":"Hayman AR, Warburton MJ, Pringle JAS, Coles B, Chambers TJ (1989) Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas. Biochem J 261:601\u2013609","journal-title":"Biochem J"},{"key":"9309_CR42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/clinchem\/23.1.89","volume":"23","author":"KW Lam","year":"1977","unstructured":"Lam KW, Yam LT (1977) Biochemical characterization of the tartrate-resistant acid phosphatase of human spleen with leukemic reticuloendotheliosis as a pyrophosphatase. Clin Chem 23:89\u201394","journal-title":"Clin Chem"},{"key":"9309_CR43","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1021\/bi00517a018","volume":"20","author":"JC Davis","year":"1981","unstructured":"Davis JC, Lin SL, Averill BA (1981) Kinetics and optical spectroscopic studies on the purple acid phosphatase from beef spleen. Biochemistry 20:4062\u20134067","journal-title":"Biochemistry"},{"key":"9309_CR44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/oxfordjournals.jbchem.a134603","volume":"95","author":"A Hara","year":"1984","unstructured":"Hara A, Sawada H, Kato T, Nakayama T, Yamamoto H, Matsumoto Y (1984) Purification and characterization of a purple acid phosphatase from rat spleen. J Biochem 95:67\u201374","journal-title":"J Biochem"},{"key":"9309_CR45","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/S0021-9258(18)89088-3","volume":"260","author":"CM Ketcham","year":"1985","unstructured":"Ketcham CM, Baumbach GA, Bazer FW, Roberts RM (1985) The type 5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin. J Biol Chem 260:5768\u20135776","journal-title":"J Biol Chem"},{"key":"9309_CR46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0006-291X(89)92705-8","volume":"165","author":"JJ \u0160t\u0115p\u00e1n","year":"1989","unstructured":"\u0160t\u0115p\u00e1n JJ, Lau KHW, Kraenzlin M, Baylink DJ (1989) Purification and N-terminal sequence of two tartrate-resistant acid phosphatases type 5 from the hairy cell leukemia spleen. Biochem Biophys Res Commun 165:1027\u20131034","journal-title":"Biochem Biophys Res Commun"},{"key":"9309_CR47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0009-9120(92)90075-4","volume":"25","author":"AJ Janckila","year":"1992","unstructured":"Janckila AJ, Latham MD, Lam KW, Chow KC, Li CY, Yam LT (1992) Heterogeneity of hairy cell tartrate-resistant acid phosphatase. Clin Biochem 25:437\u2013443","journal-title":"Clin Biochem"},{"key":"9309_CR48","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1021\/bi00083a010","volume":"32","author":"JL Orlando","year":"1993","unstructured":"Orlando JL, Zirino T, Quirk BJ, Averill BA (1993) Purification and properties of the native form of the purple acid phosphatase from bovine spleen. Biochemistry 32:8120\u20138129","journal-title":"Biochemistry"},{"key":"9309_CR49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/bj3210305","volume":"321","author":"B Ek-Rylander","year":"1997","unstructured":"Ek-Rylander B, Barkhem T, Ljusberg J, \u00d6hman L, Andersson KK, Andersson G (1997) Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase. Biochem J 321:305\u2013311","journal-title":"Biochem J"},{"key":"9309_CR50","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1016\/S0021-9258(19)81276-0","volume":"249","author":"DC Schlosnagle","year":"1974","unstructured":"Schlosnagle DC, Bazer FW, Tsibris JCM, Roberts RM (1974) An iron-containing phosphatase induced by progesterone in the uterine fluids of pigs. J Biol Chem 249:7574\u20137579","journal-title":"J Biol Chem"},{"key":"9309_CR51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00227750","volume":"105","author":"GA Baumbach","year":"1991","unstructured":"Baumbach GA, Saunders PTK, Ketcham CM, Bazer FW, Roberts RM (1991) Uteroferrin contains complex and high mannose-type oligosaccharides when synthesized in vitro. Mol Cell Biochem 105:107\u2013117","journal-title":"Mol Cell Biochem"},{"key":"9309_CR52","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/bj2770631","volume":"277","author":"AR Hayman","year":"1991","unstructured":"Hayman AR, Dryden AJ, Chambers TJ, Warburton MJ (1991) Tartrate-resistant acid phosphatase from human osteoclastomas is translated as a single polypeptide. Biochem J 277:631\u2013634","journal-title":"Biochem J"},{"key":"9309_CR53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0504287","volume":"77","author":"AJ Janckila","year":"2005","unstructured":"Janckila AJ, Parthasarathy RN, Parthasarathy LK, Seelan RS, Hsueh YC, Rissanen J, Alatalo SL, Halleen JM, Yam LT (2005) Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells. J Leukoc Biol 77:209\u2013218","journal-title":"J Leukoc Biol"},{"key":"9309_CR54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/bj3430063","volume":"343","author":"J Ljusberg","year":"1999","unstructured":"Ljusberg J, Ek-Rylander B, Andersson G (1999) Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases. Biochem J 343:63\u201369","journal-title":"Biochem J"},{"key":"9309_CR55","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1021\/bi010766r","volume":"40","author":"EG Funhoff","year":"2001","unstructured":"Funhoff EG, Ljusberg J, Wang Y, Andersson G, Averill BA (2001) Mutational analysis of the interaction between active site residues and the loop region in mammalian purple acid phosphatases. Biochemistry 40:11614\u201311622","journal-title":"Biochemistry"},{"key":"9309_CR56","doi-asserted-by":"crossref","first-page":"28370","DOI":"10.1074\/jbc.M502469200","volume":"280","author":"J Ljusberg","year":"2005","unstructured":"Ljusberg J, Wang Y, L\u00e5ng P, Norg\u00e5rd M, Dodds R, Hultenby K, Ek-Rylander B, Andersson G (2005) Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem 280:28370\u201328381","journal-title":"J Biol Chem"},{"key":"9309_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2006.03.010","volume":"449","author":"KM Fagerlund","year":"2006","unstructured":"Fagerlund KM, Ylipahkala H, Tiitinen SL, Janckila AJ, Hamilton S, M\u00e4entausta O, V\u00e4\u00e4n\u00e4nen HK, Halleen JM (2006) Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphatase. Arch Biochem Biophys 449:1\u20137","journal-title":"Arch Biochem Biophys"},{"key":"9309_CR58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0021-9258(17)31295-4","volume":"264","author":"CM Ketcham","year":"1989","unstructured":"Ketcham CM, Roberts RM, Simmen RCM, Nick HS (1989) Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta. J Biol Chem 264:557\u2013563","journal-title":"J Biol Chem"},{"key":"9309_CR59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1432-1033.1990.tb15488.x","volume":"189","author":"DK Lord","year":"1990","unstructured":"Lord DK, Cross NCP, Bevilacqua MA, Rider SH, Gorman PA, Groves AV, Moss DW, Sheer D, Cox TM (1990) Type 5 acid phosphatase. Sequence, expression and chromosomal localization of a differentiation-associated protein of the human macrophage. Eur J Biochem 189:287\u2013293","journal-title":"Eur J Biochem"},{"key":"9309_CR60","doi-asserted-by":"crossref","first-page":"24684","DOI":"10.1016\/S0021-9258(18)54284-8","volume":"266","author":"B Ek-Rylander","year":"1991","unstructured":"Ek-Rylander B, Bill P, Norg\u00e5rd M, Nilsson S, Andersson G (1991) Cloning, sequence and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone. J Biol Chem 266:24684\u201324689","journal-title":"J Biol Chem"},{"key":"9309_CR61","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1016\/S0021-9258(18)53124-0","volume":"268","author":"P Ling","year":"1993","unstructured":"Ling P, Roberts RM (1993) Uteroferrin and intracellular tartrate-resistant acid phosphatases are products of the same gene. J Biol Chem 268:6896\u20136902","journal-title":"J Biol Chem"},{"key":"9309_CR62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.abb.2004.11.029","volume":"435","author":"Y Wang","year":"2005","unstructured":"Wang Y, Norg\u00e5rd M, Andersson G (2005) N-Glycosylation influences the latency and catalytic properties of mammalian purple acid phosphatase. Arch Biochem Biophys 435:147\u2013156","journal-title":"Arch Biochem Biophys"},{"key":"9309_CR63","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.clinbiochem.2008.07.010","volume":"41","author":"T Kawaguchi","year":"2008","unstructured":"Kawaguchi T, Nakano T, Sasagawa K, Ohashi T, Miura T, Komoda T (2008) Tartrate-resistant acid phosphatase 5a and 5b contain distinct sugar moieties. Clin Biochem 41:1245\u20131249","journal-title":"Clin Biochem"},{"key":"9309_CR64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-1119(00)00186-4","volume":"250","author":"G Schenk","year":"2000","unstructured":"Schenk G, Guddat LW, Ge Y, Carrington LE, Hume DA, Hamilton S, deJersey J (2000) Identification of mammalian-like purple acid phosphatases in a wide range of plants. Gene 250:117\u2013125","journal-title":"Gene"},{"key":"9309_CR65","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1104\/pp.118.3.1015","volume":"118","author":"H Nakazato","year":"1998","unstructured":"Nakazato H, Okamato T, Nishikoori M, Washio K, Morita N, Haraguchi K, Thompson GA Jr, Okuyama H (1998) The glycosylphosphatidylinositol-anchored phosphatase from Spirodela oligorrhiza is a purple acid phosphatase. Plant Physiol 118:1015\u20131020","journal-title":"Plant Physiol"},{"key":"9309_CR66","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0378-1119(00)00305-X","volume":"255","author":"G Schenk","year":"2000","unstructured":"Schenk G, Korsinczky MLJ, Hume DA, Hamilton S, deJersey J (2000) Purple acid phosphatases from bacteria: similarities to mammalian and plant enzymes. Gene 255:419\u2013424","journal-title":"Gene"},{"key":"9309_CR67","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0305-0491(86)90152-5","volume":"83","author":"T Kato","year":"1986","unstructured":"Kato T, Hara A, Nakayama T, Sawada H, Hamatake M, Matsumoto Y (1986) Purification and characterization of purple acid phosphatase from rat bone. Comp Biochem Physiol B Biochem Mol Biol 83:813\u2013817","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"9309_CR68","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0021-9258(19)75798-6","volume":"262","author":"KH Lau","year":"1987","unstructured":"Lau KH, Freeman TK, Baylink DJ (1987) Purification and characterization of an acid phosphatase that displays phosphotyrosyl-protein phosphatase activity from bovine cortical bone matrix. J Biol Chem 262:1389\u20131397","journal-title":"J Biol Chem"},{"key":"9309_CR69","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0006-291X(90)92391-C","volume":"168","author":"JJ \u0160t\u0115p\u00e1n","year":"1990","unstructured":"\u0160t\u0115p\u00e1n JJ, Lau KHW, Mohan S, Singer FR, Baylink DJ (1990) Purification and N-terminal amino acid sequence of the tartrate-resistant acid phosphatase from human osteoclastoma: evidence for a single structure. Biochem Biophys Res Commun 168:792\u2013800","journal-title":"Biochem Biophys Res Commun"},{"key":"9309_CR70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jbmr.5650060408","volume":"6","author":"B Ek-Rylander","year":"1991","unstructured":"Ek-Rylander B, Bergman T, Andersson G (1991) Characterization of a tartrate-resistant acid phosphatase (ATPase) from rat bone: hydrodynamic properties and N-terminal amino acid sequence. J Bone Miner Res 6:365\u2013373","journal-title":"J Bone Miner Res"},{"key":"9309_CR71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0003-9861(81)90179-X","volume":"210","author":"DB Robinson","year":"1981","unstructured":"Robinson DB, Glew RH (1981) Substrate specificity of Gaucher spleen phosphoproteins phosphatase. Arch Biochem Biophys 210:186\u2013199","journal-title":"Arch Biochem Biophys"},{"key":"9309_CR72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0378-4347(01)00157-8","volume":"757","author":"Y Igarashi","year":"2001","unstructured":"Igarashi Y, Lee MY, Matsuzaki S (2001) Heparin column analysis of serum type 5 tartrate-resistant acid phosphatase isoforms. J Chromatogr B Biomed Sci Appl 757:269\u2013276","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"9309_CR73","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0021-9258(17)42257-5","volume":"269","author":"AR Hayman","year":"1994","unstructured":"Hayman AR, Cox TM (1994) Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells. J Biol Chem 269:1294\u20131300","journal-title":"J Biol Chem"},{"key":"9309_CR74","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0009-8981(02)00280-2","volume":"326","author":"AJ Janckila","year":"2002","unstructured":"Janckila AJ, Parthasarathy RN, Parthasarathy LK, Seelan RS, Yam LT (2002) Stable expression of human tartrate-resistant acid phosphatase isoforms by CHO cells. Clin Chim Acta 326:113\u2013122","journal-title":"Clin Chim Acta"},{"key":"9309_CR75","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1359\/jbmr.1999.14.3.424","volume":"14","author":"H Kaija","year":"1999","unstructured":"Kaija H, Jia J, Lindqvist Y, Andersson GN, Vihko PT (1999) Tartrate-resistant acid phosphatase: large scale production and purification of the recombinant enzyme, characterization and crystallization. J Bone Miner Res 14:424\u2013430","journal-title":"J Bone Miner Res"},{"key":"9309_CR76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0022-2836(92)91012-E","volume":"224","author":"N Str\u00e4ter","year":"1992","unstructured":"Str\u00e4ter N, Fr\u00f6hlich R, Schiemann A, Krebs B, K\u00f6rner M, Suerbaum H, Witzel H (1992) Crystallization and preliminary crystallographic data of purple acid phosphatase from red kidney bean. J Mol Biol 224:511\u2013513","journal-title":"J Mol Biol"},{"key":"9309_CR77","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1432-1327.1999.00230.x","volume":"260","author":"A Durmus","year":"1999","unstructured":"Durmus A, Eicken C, Sift BH, Kratel A, Kappl R, H\u0171ttermann J, Krebs B (1999) The active site of purple acid phosphatase from sweet potatoes (Ipomoea batatas). Metal content and spectroscopic characterization. Eur J Biochem 260:709\u2013716","journal-title":"Eur J Biochem"},{"key":"9309_CR78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/jmbi.1999.2896","volume":"290","author":"J Uppenberg","year":"1999","unstructured":"Uppenberg J, Lindqvist F, Svensson C, Ek-Rylander B, Andersson G (1999) Crystal structure of a mammalian purple acid phosphatase. J Mol Biol 290:201\u2013211","journal-title":"J Mol Biol"},{"key":"9309_CR79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/jmbi.1999.2962","volume":"291","author":"Y Lindqvist","year":"1999","unstructured":"Lindqvist Y, Johansson E, Kaija H, Vihko P, Schneider G (1999) Three-dimensional structure of a mammalian purple acid phosphatase at 2.2\u00a0A resolution with a m-(Hydr)oxo bridged di-iron center. J Mol Biol 291:135\u2013147","journal-title":"J Mol Biol"},{"key":"9309_CR80","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmb.2005.04.014","volume":"351","author":"N Str\u00e4ter","year":"2005","unstructured":"Str\u00e4ter N, Jasper B, Scholte M, Krebs B, Duff AP, Langley DB, Han R, Averill BA, Freeman HC, Guss JM (2005) Crystal structures of recombinant human purple acid phosphatase with and without an inhibitory conformation of the repression loop. J Mol Biol 351:233\u2013246","journal-title":"J Mol Biol"},{"key":"9309_CR81","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1073\/pnas.79.15.4623","volume":"79","author":"JC Davis","year":"1982","unstructured":"Davis JC, Averill BA (1982) Evidence for a spin-coupled binuclear iron unit at the active site of the purple acid phosphatase from beef spleen. Proc Natl Acad Sci USA 79:4623\u20134627","journal-title":"Proc Natl Acad Sci USA"},{"key":"9309_CR82","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1021\/bi980389r","volume":"37","author":"M Merkx","year":"1998","unstructured":"Merkx M, Averill BA (1998) The activity of oxidized bovine spleen purple acid phosphatase is due to an Fe(III)Zn(II) \u201cimpurity\u201d. Biochemistry 37:11223\u201311231","journal-title":"Biochemistry"},{"key":"9309_CR83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/abbi.1995.1275","volume":"319","author":"CJ Wynne","year":"1995","unstructured":"Wynne CJ, Hamilton SE, Dionysius DA, Beck JL, de Jersey J (1995) Studies of the catalytic mechanism of pig purple acid phosphatase. Arch Biochem Biophys 319:133\u2013141","journal-title":"Arch Biochem Biophys"},{"key":"9309_CR84","first-page":"199","volume":"6","author":"AJ Janckila","year":"1992","unstructured":"Janckila AJ, Woodford TA, Lam KW, Li CY, Yam LT (1992) Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase. Leukemia 6:199\u2013203","journal-title":"Leukemia"},{"key":"9309_CR85","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.abb.2004.01.008","volume":"424","author":"M Valizadeh","year":"2004","unstructured":"Valizadeh M, Schenk G, Nash K, Oddie GW, Guddat LW, Hume DA, de Jersey J, Burke TR Jr, Hamilton S (2004) Phosphotyrosyl peptides and analogues as substrates and inhibitors of purple acid phosphatase. Arch Biochem Biophys 424:154\u2013162","journal-title":"Arch Biochem Biophys"},{"key":"9309_CR86","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1432-1033.1996.0669w.x","volume":"238","author":"R Bresciani","year":"1996","unstructured":"Bresciani R, Von Figura K (1996) Dephosphorylation of the mannose-6-phosphate recognition marker is localized in late compartments of the endocytic route. Identification of purple acid phosphatase (uteroferrin) as the candidate phosphatase. Eur J Biochem 238:669\u2013674","journal-title":"Eur J Biochem"},{"key":"9309_CR87","doi-asserted-by":"crossref","first-page":"16590","DOI":"10.1073\/pnas.0807472105","volume":"105","author":"P Sun","year":"2008","unstructured":"Sun P, Sleat DE, Lecocq M, Hayman AR, Jadot M, Lobel P (2008) Acid phosphatase 5 is responsible for removing the mannose-6-phosphate recognition marker from lysosomal proteins. Proc Natl Acad Sci USA 105:16590\u201316595","journal-title":"Proc Natl Acad Sci USA"},{"key":"9309_CR88","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0006-291X(78)90919-1","volume":"82","author":"HD Campbell","year":"1978","unstructured":"Campbell HD, Dionysius DA, Keough DT, Wilson BE, deJersey J, Zerner B (1978) Iron-containing acid phosphatases: comparison of the enzymes from beef spleen and pig allantoic fluid. Biochem Biophys Res Commun 82:615\u2013620","journal-title":"Biochem Biophys Res Commun"},{"key":"9309_CR89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0021-9258(19)75887-6","volume":"262","author":"JC Sibille","year":"1987","unstructured":"Sibille JC, Doi K, Aisen P (1987) Hydroxyl radical formation and iron binding proteins. J Biol Chem 262:59\u201362","journal-title":"J Biol Chem"},{"key":"9309_CR90","doi-asserted-by":"crossref","first-page":"22907","DOI":"10.1074\/jbc.274.33.22907","volume":"274","author":"JM Halleen","year":"1999","unstructured":"Halleen JM, R\u00e4is\u00e4nen S, Salo JJ, Reddi SV, Roodman GD, Hentunen TA, Lehenkari PP, Kaija H, Vihko P, V\u00e4\u00e4n\u00e4nen HK (1999) Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274:22907\u201322910","journal-title":"J Biol Chem"},{"key":"9309_CR91","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/bbrc.2002.6615","volume":"292","author":"H Kaija","year":"2002","unstructured":"Kaija H, Alatalo SL, Halleen JM, Lindqvist Y, Schneider G, V\u00e4\u00e4n\u00e4nan HK, Vihko P (2002) Phosphatase and oxygen radical-generating activities of mammalian purple acid phosphatase are functionally independent. Biochem Biophys Res Commun 292:128\u2013132","journal-title":"Biochem Biophys Res Commun"},{"key":"9309_CR92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/geno.1993.1079","volume":"15","author":"R Grimes","year":"1993","unstructured":"Grimes R, Reddy SV, Leach RJ, Scarcez T, Roodman GD, Sakaguchi AY, Lalley PA, Windle JJ (1993) Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to chromosome 9. Genomics 15:421\u2013422","journal-title":"Genomics"},{"key":"9309_CR93","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/10445490050199072","volume":"19","author":"JL Vallet","year":"2000","unstructured":"Vallet JL, Fahrenkrug SC (2000) Structure of the gene for uteroferrin. DNA Cell Biol 19:689\u2013696","journal-title":"DNA Cell Biol"},{"key":"9309_CR94","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-1119(93)90420-8","volume":"130","author":"AI Cassady","year":"1993","unstructured":"Cassady AI, King AG, Cross NC, Hume DA (1993) Isolation and characterization of the genes encoding mouse and human type 5 acid phosphatase. Gene 130:201\u2013207","journal-title":"Gene"},{"key":"9309_CR95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.leu.2400532","volume":"11","author":"E Fleckenstein","year":"1997","unstructured":"Fleckenstein E, Drexler HG (1997) Tartrate-resistant acid phosphatase: gene structure and function. Leukemia 11:10\u201313","journal-title":"Leukemia"},{"key":"9309_CR96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-1119(03)00449-9","volume":"307","author":"NC Walsh","year":"2003","unstructured":"Walsh NC, Cahill M, Carninci P, Kawai J, Okazaki Y, Hayashizaki Y, Hume DA, Cassady AI (2003) Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene. Gene 307:111\u2013123","journal-title":"Gene"},{"key":"9309_CR97","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/endo-129-2-697","volume":"129","author":"AE Fliss","year":"1991","unstructured":"Fliss AE, Michel FJ, Chen CL, Hofig A, Bazer FW, Chou JY, Simmen RCM (1991) Regulation of the uteroferrin gene promoter in endometrial cells: interactions among estrogen, progesterone, and prolactin. Endocrinology 129:697\u2013704","journal-title":"Endocrinology"},{"key":"9309_CR98","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/bj2980421","volume":"298","author":"O Alcantara","year":"1994","unstructured":"Alcantara O, Reddy SV, Roodman GD, Boldt DH (1994) Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron. Biochem J 298:421\u2013425","journal-title":"Biochem J"},{"key":"9309_CR99","first-page":"637","volume":"10","author":"E Fleckenstein","year":"1996","unstructured":"Fleckenstein E, Dirks W, Dehmel U, Drexler HG (1996) Cloning and characterization of the human tartrate-resistant acid phosphatase (TRAP) gene. Leukemia 10:637\u2013643","journal-title":"Leukemia"},{"key":"9309_CR100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/10428190009148409","volume":"36","author":"EC Fleckenstein","year":"2000","unstructured":"Fleckenstein EC, Dirks WG, Drexler HG (2000) The human tartrate-resistant acid phosphatase (TRAP): involvement of the hemin responsive elements (HRE) in transcriptional regulation. Leuk Lymphoma 36:603\u2013612","journal-title":"Leuk Lymphoma"},{"key":"9309_CR101","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jbmr.5650100413","volume":"10","author":"SV Reddy","year":"1995","unstructured":"Reddy SV, Hundley JE, Windle JJ, Alcantara O, Linn R, Leach RJ, Boldt DH, Roodman GD (1995) Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. J Bone Miner Res 10:601\u2013606","journal-title":"J Bone Miner Res"},{"key":"9309_CR102","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1182\/blood.V88.6.2288.bloodjournal8862288","volume":"88","author":"SV Reddy","year":"1996","unstructured":"Reddy SV, Alcantara O, Roodman GD, Boldt DH (1996) Inhibition of tartrate-resistant acid phosphatase gene expression by hemin and protoporphyrin IX. Identification of a hemin-responsive inhibitor of transcription. Blood 88:2288\u20132297","journal-title":"Blood"},{"key":"9309_CR103","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki SI, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"9309_CR104","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1359\/jbmr.2000.15.3.451","volume":"15","author":"A Luchin","year":"2000","unstructured":"Luchin A, Purdom G, Murphy K, Clark MY, Angel N, Cassady AI, Hume DA, Ostrowski MC (2000) The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J Bone Miner Res 15:451\u2013460","journal-title":"J Bone Miner Res"},{"key":"9309_CR105","doi-asserted-by":"crossref","first-page":"33086","DOI":"10.1074\/jbc.M104299200","volume":"276","author":"M Matsumoto","year":"2001","unstructured":"Matsumoto M, Hisatake K, Nogi Y, Tsujimoto M (2001) Regulation of receptor activator of NF\u03baB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein\/interferon regulatory factor-4. J Biol Chem 276:33086\u201333092","journal-title":"J Biol Chem"},{"key":"9309_CR106","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bone.2003.11.010","volume":"34","author":"GA Partington","year":"2004","unstructured":"Partington GA, Fuller K, Chambers TJ, Pondel M (2004) Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation. Bone 34:237\u2013245","journal-title":"Bone"},{"key":"9309_CR107","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1189\/jlb.71.2.304","volume":"71","author":"KC Mansky","year":"2002","unstructured":"Mansky KC, Sulzbacher S, Purdom G, Nelson L, Hume DA, Rehli M, Ostrowski MC (2002) The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter. J Leukocyte Biol 71:304\u2013310","journal-title":"J Leukocyte Biol"},{"key":"9309_CR108","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1128\/MCB.01839-06","volume":"27","author":"R Hu","year":"2007","unstructured":"Hu R, Sharma SM, Bronisz A, Srinivasan R, Sankar U, Ostrowski MC (2007) Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Mol Cell Biol 27:4018\u20134027","journal-title":"Mol Cell Biol"},{"key":"9309_CR109","doi-asserted-by":"crossref","first-page":"20603","DOI":"10.1074\/jbc.M212093200","volume":"278","author":"Y Liu","year":"2003","unstructured":"Liu Y, Shi Z, Silveira A, Liu J, Sawadogo M, Yang H, Feng X (2003) Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation. J Biol Chem 278:20603\u201320611","journal-title":"J Biol Chem"},{"key":"9309_CR110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2004.08.009","volume":"343","author":"Z Shi","year":"2004","unstructured":"Shi Z, Silveira A, Patel P, Feng X (2004) YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation. Gene 343:117\u2013126","journal-title":"Gene"},{"key":"9309_CR111","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1074\/jbc.M409052200","volume":"280","author":"W Pan","year":"2005","unstructured":"Pan W, Mathews W, Donohue JM, Ramnaraine ML, Lynch C, Selski DJ, Walsh N, Cassady AI, Clohisy DR (2005) Analysis of distinct tartrate-resistant acid phosphatase promoter regions in transgenic mice. J Biol Chem 280:4888\u20134893","journal-title":"J Biol Chem"},{"key":"9309_CR112","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1095\/biolreprod27.5.1247","volume":"27","author":"RH Renegar","year":"1982","unstructured":"Renegar RH, Bazer FW, Roberts RM (1982) Placental transport and distribution of uteroferrin in the fetal pig. Biol Reprod 27:1247\u20131260","journal-title":"Biol Reprod"},{"key":"9309_CR113","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0021-9258(19)68096-8","volume":"257","author":"WC Buhi","year":"1982","unstructured":"Buhi WC, Ducsay CA, Bazer FW, Roberts RM (1982) Iron transfer between the purple phosphatase uteroferrin and transferrin and its possible role in iron metabolism of the fetal pig. J Biol Chem 257:1712\u20131723","journal-title":"J Biol Chem"},{"key":"9309_CR114","doi-asserted-by":"crossref","first-page":"14936","DOI":"10.1016\/S0021-9258(18)66807-3","volume":"261","author":"K Doi","year":"1986","unstructured":"Doi K, Ananaitis BC, Aisen P (1986) Absence of iron transfer from uteroferrin to transferrin. J Biol Chem 261:14936\u201314938","journal-title":"J Biol Chem"},{"key":"9309_CR115","doi-asserted-by":"crossref","first-page":"12192","DOI":"10.1016\/S0021-9258(19)38330-9","volume":"265","author":"PR Nuttleman","year":"1990","unstructured":"Nuttleman PR, Roberts RM (1990) Transfer of iron from uteroferrin (purple acid phosphatase) to transferrin related to acid phosphatase activity. J Biol Chem 265:12192\u201312199","journal-title":"J Biol Chem"},{"key":"9309_CR116","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1016\/S0021-9258(17)36541-9","volume":"269","author":"B Ek-Rylander","year":"1994","unstructured":"Ek-Rylander B, Flores M, Wendel M, Heineg\u00e5rd D, Andersson G (1994) Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269:14853\u201314856","journal-title":"J Biol Chem"},{"key":"9309_CR117","first-page":"S358","volume":"14","author":"J Ljusberg","year":"1999","unstructured":"Ljusberg J, Dodds RA, Lark MW, Gowen M, Lazner F, Kola I, Ek-Rylander B, Andersson G (1999) Tartrate-resistant acid phosphatase is proteolytically cleaved in vivo by cathepsin K. J Bone Miner Res 14:S358","journal-title":"J Bone Miner Res"},{"key":"9309_CR118","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1359\/jbmr.2003.18.10.1912","volume":"18","author":"G Andersson","year":"2003","unstructured":"Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sj\u00f6lander J, L\u00e5ng P, Norg\u00e5rd M, Wang Y, Zhang SJ (2003) TRAP as an osteopontin phosphatase. J Bone Miner Res 18:1912\u20131915","journal-title":"J Bone Miner Res"},{"key":"9309_CR119","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S8756-3282(01)00637-8","volume":"30","author":"S Razzouk","year":"2002","unstructured":"Razzouk S, Brunn JC, Qin C, Tye CE, Goldberg HA, Butler WT (2002) Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone 30:40\u201347","journal-title":"Bone"},{"key":"9309_CR120","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1359\/JBMR.040603","volume":"19","author":"J V\u00e4\u00e4r\u00e4niemi","year":"2004","unstructured":"V\u00e4\u00e4r\u00e4niemi J, Halleen JM, Kaarlonen K, Ylipahkala H, Alatalo SL, Andersson G, Kaija H, Vihko P, V\u00e4\u00e4n\u00e4nen HK (2004) Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J Bone Miner Res 19:1432\u20131440","journal-title":"J Bone Miner Res"},{"key":"9309_CR121","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1359\/jbmr.2003.18.10.1908","volume":"18","author":"JM Halleen","year":"2003","unstructured":"Halleen JM, R\u00e4is\u00e4nen SR, Alatalo SL, V\u00e4\u00e4n\u00e4nen HK (2003) Potential function for the ROS-generating activity of TRAP. J Bone Miner Res 18:1908\u20131911","journal-title":"J Bone Miner Res"},{"key":"9309_CR122","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1242\/dev.122.10.3151","volume":"122","author":"AR Hayman","year":"1996","unstructured":"Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM (1996) Mice lacking tartrate-resistant acid phosphatase (Acp5) have disrupted endochondral ossification and mild osteoporosis. Development 122:3151\u20133162","journal-title":"Development"},{"key":"9309_CR123","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1359\/jbmr.2000.15.1.103","volume":"15","author":"NZ Angel","year":"2000","unstructured":"Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA (2000) Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res 15:103\u2013110","journal-title":"J Bone Miner Res"},{"key":"9309_CR124","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/08916930701694667","volume":"41","author":"AR Hayman","year":"2008","unstructured":"Hayman AR (2008) Tartrate-resistant acid phosphatase (TRAP) and the osteoclast\/immune cell dichotomy. Autoimmunity 41:218\u2013223","journal-title":"Autoimmunity"},{"key":"9309_CR125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2567.2001.01145.x","volume":"102","author":"AJ Bune","year":"2001","unstructured":"Bune AJ, Hayman AR, Evans MJ, Cox TM (2001) Mice lacking tartrate-resistant acid phosphatase (Acp5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus. Immunology 102:103\u2013113","journal-title":"Immunology"},{"key":"9309_CR126","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1359\/jbmr.060611","volume":"21","author":"E Esfandiari","year":"2006","unstructured":"Esfandiari E, Bailey M, Stokes CR, Cox TM, Evans MJ, Hayman AR (2006) TRAP influences Th1 pathways by affecting dendritic cell function. J Bone Miner Res 21:1367\u20131376","journal-title":"J Bone Miner Res"},{"key":"9309_CR127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2005.03.133","volume":"331","author":"SR R\u00e4is\u00e4nen","year":"2005","unstructured":"R\u00e4is\u00e4nen SR, Alatalo SL, Ylipahkala H, Halleen JM, Cassady AI, Hume DA, V\u00e4\u00e4n\u00e4nen HK (2005) Macrophages overexpressing tartrate-resistant acid phosphatase show altered profile of free radical production and enhanced capacity of bacterial killing. Biochem Biophys Res Commun 331:120\u2013126","journal-title":"Biochem Biophys Res Commun"},{"key":"9309_CR128","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1242\/dev.128.23.4899","volume":"128","author":"A Suter","year":"2001","unstructured":"Suter A, Everts V, Boyde A, Jones SJ, L\u00fcllmann-Rauch R, Hartmann D, Hayman AR, Cox TM, Evans MJ, Meister T, von Figura K, Saftig P (2001) Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice. Development 128:4899\u20134910","journal-title":"Development"},{"key":"9309_CR129","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1359\/jbmr.2002.17.5.915","volume":"17","author":"TJ Sheu","year":"2002","unstructured":"Sheu TJ, Schwarz EM, O\u2019Keefe RJ, Rosier RN, Puzas JE (2002) Use of a phage display technique to identify potential osteoblast binding sites within osteoclast lacunae. J Bone Miner Res 17:915\u2013922","journal-title":"J Bone Miner Res"},{"key":"9309_CR130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.abb.2005.05.013","volume":"439","author":"N Miti\u0107","year":"2005","unstructured":"Miti\u0107 N, Valizadeh M, Leung EW, de Jersey J, Hamilton S, Hume DA, Cassady AI, Schenk G (2005) Human tartrate-resistant acid phosphatase becomes an effective ATPase upon proteolytic activation. Arch Biochem Biophys 439:154\u2013164","journal-title":"Arch Biochem Biophys"},{"key":"9309_CR131","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/clinchem\/28.3.467","volume":"28","author":"KW Lam","year":"1982","unstructured":"Lam KW, Siemens Sun T, Li CY, Yam LT (1982) Enzyme immunoassay for tartrate-resistant acid phosphatase. Clin Chem 28:467\u2013470","journal-title":"Clin Chem"},{"key":"9309_CR132","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/clinchem\/33.10.1832","volume":"33","author":"ZO Echetebu","year":"1987","unstructured":"Echetebu ZO, Cox TM, Moss DW (1987) Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase. Clin Chem 33:1832\u20131836","journal-title":"Clin Chem"},{"key":"9309_CR133","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1210\/jcem-71-2-442","volume":"71","author":"ME Kraenzlin","year":"1990","unstructured":"Kraenzlin ME, Lau KHW, Liang L, Freeman TK, Singer FR, Stepan J, Baylink DJ (1990) Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase. J Clin Endocrinol Metab 71:442\u2013451","journal-title":"J Clin Endocrinol Metab"},{"key":"9309_CR134","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/clinchem\/41.5.679","volume":"41","author":"CK Cheung","year":"1995","unstructured":"Cheung CK, Panesar NS, Haines C, Masarei J, Swaminathan R (1995) Immunoassay of a tartrate-resistant acid phosphatase in serum. Clin Chem 41:679\u2013686","journal-title":"Clin Chem"},{"key":"9309_CR135","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/clinchem\/41.10.1495","volume":"41","author":"P Chamberlain","year":"1995","unstructured":"Chamberlain P, Compston J, Cos TM, Hayman AR, Imrie RC, Reynolds K, Holmes SD (1995) Generation and characterization of monoclonal antibodies to human type 5 tartrate-resistant acid phosphatase: development of a specific immunoassay of the isoenzymes in serum. Clin Chem 41:1495\u20131499","journal-title":"Clin Chem"},{"key":"9309_CR136","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1359\/jbmr.1998.13.4.683","volume":"15","author":"JM Halleen","year":"1998","unstructured":"Halleen JM, Hentunen TA, Karp M, K\u00e4k\u00f6nen SM, Pettersson K, V\u00e4\u00e4n\u00e4nen HK (1998) Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay. J Bone Miner Res 15:683\u2013687","journal-title":"J Bone Miner Res"},{"key":"9309_CR137","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1093\/clinchem\/45.12.2150","volume":"45","author":"YR Nakasato","year":"1999","unstructured":"Nakasato YR, Janckila AJ, Halleen JM, V\u00e4\u00e4n\u00e4nen HK, Walton SP, Yam LT (1999) Clinical significance of immunoassays for type 5 tartrate-resistant acid phosphatase. Clin Chem 45:2150\u20132157","journal-title":"Clin Chem"},{"key":"9309_CR138","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/153685902760173917","volume":"21","author":"T Miyazaki","year":"2002","unstructured":"Miyazaki T, Matsunaga T, Miyazaki S, Hokari S, Komoda T (2002) Characterization of four monoclonal antibodies to recombinant human tartrate-resistant acid phosphatase. Hybridoma Hybridomics 21:191\u2013195","journal-title":"Hybridoma Hybridomics"},{"key":"9309_CR139","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0009-8981(02)00431-X","volume":"329","author":"S Miyazaki","year":"2003","unstructured":"Miyazaki S, Igarishi M, Nagata A, Tominaga Y, Onodera K, Komoda T (2003) Development of immunoassays for type 5 tartrate-resistant acid phosphatase in human serum. Clin Chim Acta 329:109\u2013115","journal-title":"Clin Chim Acta"},{"key":"9309_CR140","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.2000.15.7.1337","volume":"15","author":"JM Halleen","year":"2000","unstructured":"Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, V\u00e4\u00e4n\u00e4nen HK (2000) Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 15:1337\u20131345","journal-title":"J Bone Miner Res"},{"key":"9309_CR141","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/clinchem\/47.1.74","volume":"47","author":"AJ Janckila","year":"2001","unstructured":"Janckila AJ, Takahashi K, Sun SZ, Yam LT (2001) Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 47:74\u201380","journal-title":"Clin Chem"},{"key":"9309_CR142","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00223-001-2122-7","volume":"71","author":"JM Halleen","year":"2002","unstructured":"Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, V\u00e4\u00e4n\u00e4nen HK (2002) Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int 71:20\u201325","journal-title":"Calcif Tissue Int"},{"key":"9309_CR143","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cca.2006.08.021","volume":"376","author":"T Ohashi","year":"2007","unstructured":"Ohashi T, Igarashi Y, Mochizuki Y, Miura T, Inaba N, Katayama K, Tomonaga T, Nomura F (2007) Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b. Clin Chim Acta 376:205\u2013212","journal-title":"Clin Chim Acta"},{"issue":"5\u20136","key":"9309_CR144","first-page":"223","volume":"55","author":"H Ylipahkala","year":"2009","unstructured":"Ylipahkala H, Fagerlund KM, Janckila A, Houston B, Laurie D, Halleen JM (2009) Specificity and clinical performance of two commercial TRAP 5b assays. J Clin Lab 55(5\u20136):223\u2013228","journal-title":"J Clin Lab"},{"key":"9309_CR145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/clinchem\/46.4.469","volume":"46","author":"M Nakanishi","year":"2000","unstructured":"Nakanishi M, Yoh K, Miura T, Ohashi T, Rai SK, Uchida K (2000) Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum. Clin Chem 46:469\u2013473","journal-title":"Clin Chem"},{"key":"9309_CR146","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cccn.2004.04.021","volume":"347","author":"AJ Janckila","year":"2004","unstructured":"Janckila AJ, Simons RM, Yam LT (2004) Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin. Clin Chim Acta 347:157\u2013167","journal-title":"Clin Chim Acta"},{"key":"9309_CR147","first-page":"347","volume":"54","author":"KM Fagerlund","year":"2008","unstructured":"Fagerlund KM, Janckila AJ, Ylipahkala H, Tiitinen SL, Nenonen A, Cheng S, Uusi-Rasi K, Yam LT, V\u00e4\u00e4n\u00e4nen HK, Halleen JM (2008) Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment. Clin Lab 54:347\u2013354","journal-title":"Clin Lab"},{"key":"9309_CR148","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1373\/clinchem.2003.029355","volume":"50","author":"SL Alatalo","year":"2004","unstructured":"Alatalo SL, Ivaska KK, Wagnespack SG, Econs MJ, V\u00e4\u00e4n\u00e4nen HK, Halleen JM (2004) Osteoclast-derived tartrate-resistant acid phosphatase 5b in Albers-Schoenberg disease (type II autosomal-dominant osteopetrosis). Clin Chem 50:883\u2013890","journal-title":"Clin Chem"},{"key":"9309_CR149","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1359\/jbmr.2003.18.1.134","volume":"18","author":"SL Alatalo","year":"2003","unstructured":"Alatalo SL, Peng Z, Janckila AJ, Kaija H, Vihko P, V\u00e4\u00e4n\u00e4nen HK, Halleen JM (2003) A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum. J Bone Miner Res 18:134\u2013139","journal-title":"J Bone Miner Res"},{"key":"9309_CR150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-007-9091-4","volume":"82","author":"JP Rissanen","year":"2008","unstructured":"Rissanen JP, Suominen MI, Peng Z, Halleen JM (2008) Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int 82:108\u2013115","journal-title":"Calcif Tissue Int"},{"key":"9309_CR151","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/clinchem\/46.11.1751","volume":"46","author":"SL Alatalo","year":"2000","unstructured":"Alatalo SL, Halleen JM, Hentunen TA, M\u00f6nkk\u00f6nen J, V\u00e4\u00e4n\u00e4nen HK (2000) Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into culture medium. Clin Chem 46:1751\u20131754","journal-title":"Clin Chem"},{"key":"9309_CR152","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00043426-200401000-00003","volume":"26","author":"CJ Chen","year":"2004","unstructured":"Chen CJ, Chao TY, Chu DM, Janckila AJ, Cheng SN (2004) Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation. J Pediatr Hematol Oncol 26:5\u20138","journal-title":"J Pediatr Hematol Oncol"},{"key":"9309_CR153","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0272-6386(03)00203-8","volume":"41","author":"P Chu","year":"2003","unstructured":"Chu P, Chao TY, Lin YF, Janckila AJ, Yam LT (2003) Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis 41:1052\u20131059","journal-title":"Am J Kidney Dis"},{"key":"9309_CR154","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1359\/jbmr.2003.18.5.852","volume":"18","author":"C Capparelli","year":"2003","unstructured":"Capparelli C, Morony S, Warmington K, Adamu S, Lacey D, Dunstan CR, Stouch B, Martin S, Kostenuik PJ (2003) Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats. J Bone Miner Res 18:852\u2013858","journal-title":"J Bone Miner Res"},{"key":"9309_CR155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00774-008-0002-1","volume":"27","author":"JP Rissanen","year":"2009","unstructured":"Rissanen JP, Ylipahkala H, Fagerlund KM, Long C, Vaananen HK, Halleen JM (2009) Improved methods for testing antiresorptive compounds in human osteoclast cultures. J Bone Miner Metab 27:105\u2013109","journal-title":"J Bone Miner Metab"},{"key":"9309_CR156","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","volume":"13","author":"SL Greenspan","year":"1998","unstructured":"Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13:1431\u20131438","journal-title":"J Bone Miner Res"},{"key":"9309_CR157","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0272-2712(18)30050-7","volume":"20","author":"HW Woitge","year":"2000","unstructured":"Woitge HW, Seibel MJ (2000) Risk assessment for osteoporosis II. Biochemical markers of bone turnover: bone resorption indices. Clin Lab Med 20:503\u2013525","journal-title":"Clin Lab Med"},{"key":"9309_CR158","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z","volume":"88","author":"LM Demers","year":"2000","unstructured":"Demers LM, Costa L, Lipton A (2000) Biochemical markers and skeletal metastasis. Cancer 88:2919\u20132926","journal-title":"Cancer"},{"key":"9309_CR159","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1210\/jc.2003-030910","volume":"88","author":"B Fohr","year":"2003","unstructured":"Fohr B, Dunstan CR, Seibel MJ (2003) Markers of bone remodeling in metastatic bone disease. J Clin Endocrinol Metab 88:5059\u20135075","journal-title":"J Clin Endocrinol Metab"},{"key":"9309_CR160","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","volume":"13","author":"R Hannon","year":"1998","unstructured":"Hannon R, Blumsohn A, Naylor K, Eastell R (1998) Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res 13:1124\u20131133","journal-title":"J Bone Miner Res"},{"key":"9309_CR161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bone.2003.04.002","volume":"34","author":"RA Hannon","year":"2004","unstructured":"Hannon RA, Clowes JA, Eagleton AC, Hadari AA, Eastell R, Blumsohn A (2004) Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Bone 34:197\u2013204","journal-title":"Bone"},{"key":"9309_CR162","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1359\/JBMR.050403","volume":"20","author":"A Nenonen","year":"2005","unstructured":"Nenonen A, Cheng S, Ivaska KK, Alatalo SL, Lehtim\u00e4ki T, Schmidt-Gayk H, Uusi-Rasi K, Heionen A, Kannus P, Siev\u00e4nen H, Vuori I, V\u00e4\u00e4n\u00e4nen HK, Halleen JM (2005) Serum TRAP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover. J Bone Miner Res 20:1804\u20131812","journal-title":"J Bone Miner Res"},{"key":"9309_CR163","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1359\/JBMR.0301244","volume":"19","author":"P Gerdhem","year":"2004","unstructured":"Gerdhem P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, Pettersson K, V\u00e4\u00e4n\u00e4nen HK, \u00c5kesson K, Obrant KJ (2004) Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 19:386\u2013393","journal-title":"J Bone Miner Res"},{"issue":"Suppl II","key":"9309_CR164","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0093-7754(01)90233-7","volume":"28","author":"A Lipton","year":"2001","unstructured":"Lipton A, Costa L, Ali S, Demers L (2001) Use of markers of bone turnover for monitoring bone metastasis and the response to therapy. Semin Oncol 28(Suppl II):54\u201359","journal-title":"Semin Oncol"},{"issue":"Suppl 1","key":"9309_CR165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0305-7372(06)80002-2","volume":"32","author":"F Saad","year":"2006","unstructured":"Saad F (2006) Optimizing patient therapy: the role of bone markers? Cancer Treat Rev 32(Suppl 1):3\u20136","journal-title":"Cancer Treat Rev"},{"key":"9309_CR166","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ctrv.2008.05.001","volume":"34","author":"R Coleman","year":"2008","unstructured":"Coleman R, Brown J, Terpos E, Lipton A, Smith MR, Cook R, Major P (2008) Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions. Cancer Treat Rev 34:629\u2013639","journal-title":"Cancer Treat Rev"},{"key":"9309_CR167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02967492","volume":"8","author":"N Wada","year":"2001","unstructured":"Wada N, Fujisaka M, Ishii S, Ikeda T, Kitajima M (2001) Evaluation of bone metabolic markers in breast cancer with bone metastasis. Breast Cancer 8:131\u2013137","journal-title":"Breast Cancer"},{"key":"9309_CR168","first-page":"1011","volume":"23","author":"B Capeller","year":"2003","unstructured":"Capeller B, Caffier H, Sutterlin MW, Dietl J (2003) Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastasis in human breast cancer. Anticancer Res 23:1011\u20131016","journal-title":"Anticancer Res"},{"key":"9309_CR169","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/1078-0432.544.11.2","volume":"15","author":"TY Chao","year":"2005","unstructured":"Chao TY, Yu JC, Ku CH, Chen MM, Lee SH, Janckila AJ, Yam LT (2005) Tartrate-resistant acid phosphatase 5b is a useful marker for extensive bone metastasis in breast cancer patients. Clin Cancer Res 15:544\u2013550","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"9309_CR170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0305-7372(06)80005-8","volume":"32","author":"A Lipton","year":"2006","unstructured":"Lipton A (2006) Biochemical bone markers in breast cancer. Cancer Treat Rev 32(Suppl 1):20\u201322","journal-title":"Cancer Treat Rev"},{"key":"9309_CR171","first-page":"4095","volume":"23","author":"M Koizumi","year":"2003","unstructured":"Koizumi M, Takahashi S, Ogata E (2003) Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis. Anticancer Res 23:4095\u20134099","journal-title":"Anticancer Res"},{"key":"9309_CR172","first-page":"3127","volume":"26","author":"J Korpela","year":"2006","unstructured":"Korpela J, Tiitinen SL, Hiekkanen H, Halleen JM, Selander KS, V\u00e4\u00e4n\u00e4nen HK, Suominen P, Helenius H, Salminen E (2006) Serum TRAP 5b and ICTP as markers of bone metastasis in breast cancer. Anticancer Res 26:3127\u20133132","journal-title":"Anticancer Res"},{"key":"9309_CR173","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.bjc.6603285","volume":"95","author":"N Voorzanger-Rousselot","year":"2006","unstructured":"Voorzanger-Rousselot N, Juillet F, Mareau E, Zimmermann J, Kalabic T, Garnero P (2006) Association of 12 serum biochemical markers of angiogenesis, tumor invasion and bone turnover with bone metastasis from breast cancer: a cross-sectional and longitudinal evaluation. Br J Cancer 95:506\u2013514","journal-title":"Br J Cancer"},{"key":"9309_CR174","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ijc.11247","volume":"106","author":"E Terpos","year":"2003","unstructured":"Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A (2003) Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Int J Cancer 106:455\u2013457","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"9309_CR175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0305-7372(06)80004-6","volume":"32","author":"E Terpos","year":"2006","unstructured":"Terpos E (2006) Biochemical markers of bone metabolism in multiple myeloma. Cancer Treat Rev 32(Suppl 1):15\u201319","journal-title":"Cancer Treat Rev"},{"key":"9309_CR176","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02694481","volume":"138","author":"NV Lyubimova","year":"2004","unstructured":"Lyubimova NV, Pashkov MV, Tyulyandin SA, Gol\u2019dberg VE, Kushlinskii NE (2004) Tartrate-resistant acid phosphatase as a marker of bone metastasis in patients with breast cancer and prostate cancer. Bull Exp Biol Med 138:77\u201379","journal-title":"Bull Exp Biol Med"},{"key":"9309_CR177","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ijc.20314","volume":"111","author":"K Jung","year":"2004","unstructured":"Jung K, Lein M, Stephan C, Von H\u00f6sslin K, Semjonow A, Sinha P, Loening SA, Schnorr D (2004) Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Int J Cancer 111:783\u2013791","journal-title":"Int J Cancer"},{"key":"9309_CR178","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/02841860500327586","volume":"44","author":"E Salminen","year":"2005","unstructured":"Salminen E, Ala-Houhala M, Korppela J, Varpula M, Tiitenen SL, Halleen JM, V\u00e4\u00e4n\u00e4nen HK (2005) Serum tartrate-resistant acid phosphatase 5b (TRAP 5b) as a marker of skeletal changes in prostate cancer. Acta Oncol 44:742\u2013747","journal-title":"Acta Oncol"},{"key":"9309_CR179","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1464-410X.2006.06604.x","volume":"99","author":"A Hegele","year":"2007","unstructured":"Hegele A, Wahl HG, Varga Z, Sevinc S, Koliva L, Schrader AJ, Hofmann R, Olbert P (2007) Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer. BJU Int 99:330\u2013334","journal-title":"BJU Int"},{"key":"9309_CR180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1442-2042.2008.02029.x","volume":"15","author":"C Ozu","year":"2008","unstructured":"Ozu C, Nakashima J, Horiguchi Y, Oya M, Ohigashi T, Murai M (2008) Prediction of bone metastasis by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. Int J Urol 15:419\u2013422","journal-title":"Int J Urol"},{"key":"9309_CR181","first-page":"4879","volume":"26","author":"EK Salminen","year":"2006","unstructured":"Salminen EK, Kallioinen MJ, Ala-Houhala MA, Vihinen PP, Tiitinen SL, Varpula M, Vahlberg TJ (2006) Survival markers related to bone metastasis in prostate cancer. Anticancer Res 26:4879\u20134884","journal-title":"Anticancer Res"},{"key":"9309_CR182","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1055-9965.EPI-05-0492","volume":"15","author":"DJ Leeming","year":"2006","unstructured":"Leeming DJ, Koizumi M, Byrjalsen I, Li B, Qvist P, Tanko LB (2006) The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastasis in breast, prostate, or lung cancer patients. Cancer Epidemiol Biomarkers Prev 15:32\u201338","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9309_CR183","first-page":"3193","volume":"24","author":"W Ebert","year":"2004","unstructured":"Ebert W, Muley TH, Herb KP, Schmidt-Gayk H (2004) Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients. Anticancer Res 24:3193\u20133202","journal-title":"Anticancer Res"},{"key":"9309_CR184","first-page":"1231","volume":"33","author":"S Avnet","year":"2008","unstructured":"Avnet S, Longhi A, Salerno M, Halleen JM, Perut F, Granchi D, Ferrari S, Bertoni F, Giunti A, Baldini N (2008) Increased osteoclast activity is associated with aggressiveness of osteosarcoma. Int J Oncol 33:1231\u20131238","journal-title":"Int J Oncol"},{"key":"9309_CR185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/172460080201700406","volume":"17","author":"A Martinetti","year":"2002","unstructured":"Martinetti A, Seregni E, Ripamonti C, Ferrari L, De Conno F, Miceli R, Pallotti F, Coliva A, Biancolini D, Bombardieri E (2002) Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate. Int J Biol Markers 17:253\u2013258","journal-title":"Int J Biol Markers"},{"key":"9309_CR186","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4065\/82.8.917","volume":"82","author":"SH Tsai","year":"2007","unstructured":"Tsai SH, Chen CY, Ku CH, Janckila AJ, Yam LT, Yu JC, Chuang KW, Chao TY (2007) The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis. Mayo Clin Proc 82:917\u2013926","journal-title":"Mayo Clin Proc"},{"key":"9309_CR187","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0609.2003.02823.x","volume":"70","author":"E Terpos","year":"2003","unstructured":"Terpos E, Viniou N, de la Fuente J, Meletis J, Voskaridou E, Karkantaris C, Vaipou los G, Palermos J, Yataganas X, Goldman JM, Rahemtulla A (2003) Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and \u03b22-microglobulin in multiple myeloma. Eur J Haematol 70:34\u201342","journal-title":"Eur J Haematol"},{"key":"9309_CR188","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0009-8981(00)00338-7","volume":"301","author":"K Takahashi","year":"2000","unstructured":"Takahashi K, Janckila AJ, Sun SZ, Lederer ED, Ray PC, Yam LT (2000) Electrophoretic study of tartrate-resistant acid phosphatase in endstage renal disease and rheumatoid arthritis. Clin Chim Acta 301:147\u2013158","journal-title":"Clin Chim Acta"},{"key":"9309_CR189","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","volume":"69","author":"S Yamada","year":"2008","unstructured":"Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y (2008) Utility of serum tartrate-resistant acid phosphatase (TRAP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Clin Endocrinol 69:189\u2013196","journal-title":"Clin Endocrinol"},{"key":"9309_CR190","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ndt\/gfh672","volume":"20","author":"I Avbersek-Luznik","year":"2005","unstructured":"Avbersek-Luznik I, Balon BP, Rus I, Marc J (2005) Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant 20:566\u2013570","journal-title":"Nephrol Dial Transplant"},{"key":"9309_CR191","first-page":"69","volume":"51","author":"J Ma\u0142yszko","year":"2006","unstructured":"Ma\u0142yszko J, Ma\u0142yszko JS, Pawlak K, Wo\u0142czy\u0144ski S, My\u015bliwiec M (2006) Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients. Adv Med Sci 51:69\u201372","journal-title":"Adv Med Sci"},{"key":"9309_CR192","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","volume":"82","author":"K Shidara","year":"2008","unstructured":"Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimura E, Nishizawa Y (2008) Serum levels of TRAP 5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients. Calcif Tissue Int 82:278\u2013287","journal-title":"Calcif Tissue Int"},{"key":"9309_CR193","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s11255-007-9254-2","volume":"39","author":"BS Peters","year":"2007","unstructured":"Peters BS, Moyses RM, Jorgetti V, Martini LA (2007) Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder. Int Urol Nephrol 39:1251\u20131256","journal-title":"Int Urol Nephrol"},{"key":"9309_CR194","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1359\/jbmr.080610","volume":"23","author":"A Fahrleitner-Pammer","year":"2008","unstructured":"Fahrleitner-Pammer A, Herberth J, Browning SR, Obermayer-Pietsch B, Wirnsberger G, Holzer H, Dobnig H, Malluche HH (2008) Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res 23:1850\u20131858","journal-title":"J Bone Miner Res"},{"key":"9309_CR195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.moo.0000127830.72761.00","volume":"16","author":"P Garnero","year":"2004","unstructured":"Garnero P, Delmas PD (2004) Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers. Curr Opin Rheumatol 16:428\u2013434","journal-title":"Curr Opin Rheumatol"},{"key":"9309_CR196","first-page":"943","volume":"152","author":"EM Gravallese","year":"1998","unstructured":"Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943\u2013951","journal-title":"Am J Pathol"},{"key":"9309_CR197","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH672>3.0.CO;2-W","volume":"192","author":"I Itonaga","year":"2000","unstructured":"Itonaga I, Fujikawa Y, Sabokbar A, Murray DW, Athanasou NA (2000) Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent. J Pathol 192:97\u2013104","journal-title":"J Pathol"},{"key":"9309_CR198","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0009-8981(02)00026-8","volume":"320","author":"AJ Janckila","year":"2002","unstructured":"Janckila AJ, Neustadt DH, Nakasato YR, Halleen JM, Hentunen T, Yam LT (2002) Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clin Chim Acta 320:49\u201358","journal-title":"Clin Chim Acta"},{"key":"9309_CR199","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cccn.2005.03.039","volume":"359","author":"TY Chao","year":"2005","unstructured":"Chao TY, Lee SH, Chen MM, Neustadt DH, Chaudhry UA, Yam LT, Janckila AJ (2005) Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a. Clin Chim Acta 359:132\u2013140","journal-title":"Clin Chim Acta"},{"key":"9309_CR200","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/ard.2007.075085","volume":"67","author":"\u00c9 Toussirot","year":"2008","unstructured":"Toussirot \u00c9, Dumoulin G, Saas P, Nguyen NU, Le Hu\u00e9d\u00e9 G, Wendling D (2008) Increased tartrate-resistant acid phosphatase serum levels in ankylosing spondylitis and relationship with the inflammatory process. Ann Rheum Dis 67:430\u2013431","journal-title":"Ann Rheum Dis"},{"key":"9309_CR201","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1359\/jbmr.080329","volume":"23","author":"AJ Janckila","year":"2008","unstructured":"Janckila AJ, Neustadt DH, Yam LT (2008) Significance of serum TRAP in rheumatoid arthritis. J Bone Miner Res 23:1287\u20131295","journal-title":"J Bone Miner Res"},{"key":"9309_CR202","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajcp\/104.4.397","volume":"104","author":"H Yaziji","year":"1995","unstructured":"Yaziji H, Janckila AJ, Lear SC, Martin AW, Yam LT (1995) Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues. Am J Clin Pathol 104:397\u2013402","journal-title":"Am J Clin Pathol"},{"key":"9309_CR203","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1309\/DGEA9BE2VE5VCFYH","volume":"127","author":"AJ Janckila","year":"2007","unstructured":"Janckila AJ, Slone SP, Lear SC, Martin A, Yam LT (2007) Tartrate-resistant acid phosphatase as an immunohistochemical marker for inflammatory macrophages. Am J Clin Pathol 127:556\u2013566","journal-title":"Am J Clin Pathol"},{"key":"9309_CR204","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1469-7580.2000.19630433.x","volume":"196","author":"AR Hayman","year":"2000","unstructured":"Hayman AR, Bune AJ, Cox TM (2000) Widespread expression of tartrate-resistant acid phosphatase (Acp5) in the mouse embryo. J Anat 196:433\u2013441","journal-title":"J Anat"},{"key":"9309_CR205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/002215540004800207","volume":"48","author":"AR Hayman","year":"2000","unstructured":"Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM (2000) Osteoclastic tartrate-resistant acid phosphatase (Acp5): its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem 48:219\u2013227","journal-title":"J Histochem Cytochem"},{"key":"9309_CR206","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/002215540104900312","volume":"49","author":"P L\u00e5ng","year":"2001","unstructured":"L\u00e5ng P, Schultzberg M, Andersson G (2001) Expression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system. J Histochem Cytochem 49:379\u2013396","journal-title":"J Histochem Cytochem"},{"key":"9309_CR207","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00018-005-4550-4","volume":"62","author":"P L\u00e5ng","year":"2005","unstructured":"L\u00e5ng P, Andersson G (2005) Differential expression of monomeric and proteolytically processed forms of purple\/tartrate-resistant acid phosphatase in rat tissues. Cell Mol Life Sci 62:905\u2013918","journal-title":"Cell Mol Life Sci"},{"key":"9309_CR208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5414\/CNP71387","volume":"71","author":"AJ Janckila","year":"2009","unstructured":"Janckila AJ, Lederer ED, Price BA, Yam LT (2009) Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease. Clin Nephrol 71:387\u2013396","journal-title":"Clin Nephrol"},{"issue":"3","key":"9309_CR209","doi-asserted-by":"crossref","first-page":"e1713","DOI":"10.1371\/journal.pone.0001713","volume":"5","author":"P L\u00e5ng","year":"2008","unstructured":"L\u00e5ng P, van Harmelen V, Ryden M, Kaaman M, Parini P, Carneheim C, Cassady AI, Hume DA, Andersson G, Arner P (2008) Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity. PloS ONE 5(3):e1713","journal-title":"PloS ONE"},{"key":"9309_CR210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","volume":"14","author":"H Tilg","year":"2008","unstructured":"Tilg H, Moschen AR (2008) Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14:222\u2013231","journal-title":"Mol Med"},{"key":"9309_CR211","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796\u20131808","journal-title":"J Clin Invest"},{"key":"9309_CR212","doi-asserted-by":"crossref","unstructured":"Shih KC, Janckila AJ, Kwok CF, Ho LT, Chou YC, Chao TY (2009) Effects of exercise on insulin sensitivity, inflammatory cytokines and serum tartrate-resistant acid phosphatase 5a in obese Chinese male adolescents. Metabolism (in press)","DOI":"10.1016\/j.metabol.2009.06.035"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-009-9309-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-009-9309-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-009-9309-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T14:49:32Z","timestamp":1685198972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-009-9309-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,14]]},"references-count":212,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9309"],"URL":"https:\/\/doi.org\/10.1007\/s00223-009-9309-8","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,14]]}}}